Colorectal cancer Archives - Seleniumfacts.com

Selenium deficiency, especially as manifested in low circulating levels of selenoprotein P, is associated significantly with an increased risk of colorectal cancer incidence and mortality [Pal 2024; Brezina 2025]. SELENOP is a selenium-dependent glycoprotein that is the primary transporter of selenium to the tissues and organs. SELENOP also acts to reduce oxidative stress and systemic inflammation [Schöttker 2024; Brezina 2025].

Newspaper article about cancer — Colorectal cancer risk is elevated in selenium and SELENOP deficiency. Serum SELENOP concentration is perhaps the single most useful parameter for prognosis once the diagnosis has been made. SELENOP concentrations below 2.5 mg/L indicate severe deficiency. Concentrations below 5.0 mg/L suggest elevated risk.

In the Colorectal Cancer Study of Austria (CORSA Study), researchers analyzed data from 519 participants (n = 153 tumor-free controls, n = 255 patients with adenomas, and n = 111 patients with colorectal cancer). The median age of the study participants was 65 years. Nearly two-thirds of the study participants were male. The study participants’ median plasma selenium concentration was a very low 65.7 mcg/L. Their median SELENOP concentration was also low: 2.7 mg/L. During a median follow-up period of 5,424 days (almost 15 years), there were 210 deaths (40 %) [Brezina 2025]. read more

Milestones in early selenium research

1817 Swedish chemist Jöns Jakob Berzelius discovers selenium

1957 Biochemist Klaus Schwarz shows that selenium in microscopic amounts has a vital importance for mammalian health

1969 Professor J.T. Rotruck discovers that selenium has a biochemical role as a component of the antioxidant enzyme glutathione peroxidase

1969 Professors R.J. Shamberger and D.V. Frost report a possible protective effect of selenium against cancer in humans

1973 Professor J.T. Rotruck identifies the enzyme glutathione peroxidase as a selenium-dependent protein

1977 Professor G.N. Schrauzer publishes cancer mortality correlation studies showing an inverse correlation between dietary intakes of selenium and cancer mortality in 27 countries

1988 Professor G.Q Yang summarizes the lessons learned about the selenium-related endemic diseases Keshan disease and Kashin-Beck disease and about the importance of adequate daily selenium intakes

1989 Professor G.G. Duthie publishes evidence for a role of selenium in the prevention of cardiovascular disease

1993 Researcher W.J. Blot publishes the results of the Nutrition Intervention Trials in Linxian, China, showing that supplementation with a combination of selenium and other antioxidants reduces the risk of cancer

1994 Professor G.N. Schrauzer publishes evidence that selenium is important in the maintenance and therapy of HIV-infected patients

1996 Professor Larry Clark publishes the results of a randomized controlled trial – the Nutritional Prevention of Cancer study -- that shows selenium's cancer-protective effects on colon cancer, lung cancer, and prostate cancer

1997 Professor G.F. Combs summarizes the evidence for the protective effects of selenium against cancer

1999 Professor J.E. Oldfield publishes his Selenium World Atlas, mapping areas of selenium deficiency around the world

2000 Researcher O.A. Levander publishes evidence showing an anti-viral effect of selenium

2002 Researcher R. Gärtner shows that supplementation with selenium reduces inflammation in patients with autoimmune thyroiditis

2002 Researcher Margaret Rayman presents the arguments for increasing selenium intakes to realize selenium’s antioxidant and anti-viral and anti-inflammatory effects as well as selenium’s enhancement of immune function and reproductive success.

Tag: Colorectal cancer

Selenoprotein P Status and Colorectal Cancer Mortality